{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T09:27:50Z","timestamp":1772702870654,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s12471-023-01765-4","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T13:02:43Z","timestamp":1677157363000},"page":"87-88","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy: a\u00a0need or not?"],"prefix":"10.1007","volume":"31","author":[{"given":"Joris R.","family":"de Groot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"key":"1765_CR1","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1056\/NEJMra000650","volume":"345","author":"HV Huikuri","year":"2001","unstructured":"Huikuri\u00a0HV, Castellanos\u00a0A, Myerburg\u00a0RJ. Sudden death due to cardiac arrhythmias. N\u00a0Engl J Med. 2001;345:1473\u201382.","journal-title":"N Engl J Med"},{"key":"1765_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa043399","volume":"352","author":"GH Bardy","year":"2005","unstructured":"Bardy\u00a0GH, Lee\u00a0KL, Mark\u00a0DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N\u00a0Engl J Med. 2005;352:225\u201337.","journal-title":"N Engl J Med"},{"key":"1765_CR3","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","volume":"337","author":"Investigators TAVIDA","year":"1997","unstructured":"Investigators TAVIDA. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N\u00a0Engl J Med. 1997;337:1576\u201383.","journal-title":"N Engl J Med"},{"key":"1765_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1161\/CIRCULATIONAHA.111.089425","volume":"126","author":"M Hulleman","year":"2012","unstructured":"Hulleman\u00a0M, Berdowski\u00a0J, de Groot\u00a0JR, et al. Implantable cardioverter-defibrillators have reduced the incidence of resuscitation for out-of-hospital cardiac arrest caused by lethal arrhythmias. Circulation. 2012;126:815\u201321.","journal-title":"Circulation"},{"key":"1765_CR5","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld\u00a0K, Tfelt-Hansen\u00a0J, de Riva\u00a0M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart\u00a0J. 2022;43:3997\u20134126.","journal-title":"Eur Heart J"},{"key":"1765_CR6","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1608029","author":"L Kober","year":"2016","unstructured":"Kober\u00a0L, Thune\u00a0JJ, Nielsen\u00a0JC, et\u00a0al. Defibrillator implantation in patients with nonischemic systolic heart failure. N\u00a0Engl J Med. 2016. https:\/\/doi.org\/10.1056\/nejmoa1608029.","journal-title":"N Engl J Med"},{"key":"1765_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s12471-022-01718-3","author":"DA Theuns","year":"2022","unstructured":"Theuns\u00a0DA, Verstraelen\u00a0TE, van der Lingen\u00a0ACJ, et al. Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy. Neth Heart\u00a0J. 2022. https:\/\/doi.org\/10.1007\/s12471-022-01718-3.","journal-title":"Neth Heart J"},{"key":"1765_CR8","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1056\/NEJMoa032423","volume":"350","author":"MR Bristow","year":"2004","unstructured":"Bristow\u00a0MR, Saxon\u00a0LA, Boehmer\u00a0J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N\u00a0Engl J Med. 2004;350:2140\u201350.","journal-title":"N Engl J Med"},{"key":"1765_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jchf.2021.02.013","volume":"9","author":"B Doran","year":"2021","unstructured":"Doran\u00a0B, Mei\u00a0C, Varosy\u00a0PD, et\u00a0al. The addition of a\u00a0defibrillator to resynchronization therapy decreases mortality in patients with nonischemic cardiomyopathy. JACC Heart Fail. 2021;9:439\u201349.","journal-title":"JACC Heart Fail"},{"key":"1765_CR10","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/europace\/euab012","volume":"23","author":"TE Verstraelen","year":"2021","unstructured":"Verstraelen\u00a0TE, van Barreveld\u00a0M, van Dessel\u00a0P, et al. Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death. Europace. 2021;23:887\u201397.","journal-title":"Europace"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-023-01765-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12471-023-01765-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-023-01765-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T13:20:04Z","timestamp":1677158404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12471-023-01765-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1765"],"URL":"https:\/\/doi.org\/10.1007\/s12471-023-01765-4","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]},"assertion":[{"value":"6 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.R.\u00a0de Groot received research grants through his institution from Atricure, Bayer, Boston Scientific, Daiichi Sankyo, Johnson&Johnson and Medtronic, and honoraria\/speakers fees from Atricure Inc, Bayer, Biotronik, CVOI, Daiichi Sankyo, Medtronic, Novartis, Servier.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}